Breast Lesion Localization Methods Market, By Technique (Wire Guided Localization, Radio Guided Occult Lesion Localization, Radioactive Seed Localization, Magnetic Tracers, and Ultrasound Guided Surgery), End User (Hospitals, Specialized Clinics, Research Institutes, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Published On : Nov 2019 |
  • Pages : 175 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Breast Lesion Localization Methods Market– Breakthrough in Breast Cancer Diagnosis

Breast cancer is a condition caused by an uncontrolled multiplication of breast cells that form a lump, which may be malignant or non-malignant in nature. Such cells usually form tumors that can often be observed on an x-ray or felt as a lump. Increasing prevalence of breast cancer, increasing awareness for treatment, presence of favorable reimbursement policy in developed and emerging economies, and increasing product development are expected to drive growth of the breast lesion localization methods market.

The global breast lesion localization methods market size was valued at US$ 530.2 million in 2018 and is expected to exhibit a CAGR of 10.7% over the forecast period (2019–2027).

Figure 1. Global Breast Lesion Localization Methods Market Value (US$ Mn), by Region, 2018

Breast Lesion Localization Methods  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing incidence and prevalence of breast cancer is expected to drive growth of the global breast lesion localization methods market

Increasing prevalence of breast cancer in developed and emerging economies is expected to propel the breast lesion localization methods market growth during the forecast period. According to Breastcancer.org, in 2019, in the U.S., around 268,600 cases of invasive breast cancer are expected to be diagnosed along with over 62,930 cases of non-invasive breast cancer. This in turn creates a highly conducive environment for growth of the global breast lesion localization methods market in the near future.

Moreover, incessant rise in population in emerging economies such as India and increasing focus towards strengthening healthcare infrastructure in the developing economies are expected to drive growth of the breast lesion localization methods market in the near future. For instance, according to The Pink Initiative and Breast Cancer Statistics in India, breast cancer is the most common cancer in most cities in India and second most common in the rural areas, and accounts for 25% to 32% of all female cancers.

However, major players operating in the market are focused towards development of new products to expand their product portfolio, which in turn is expected to propel the market growth over the forecast period. For instance, in January 2019, the U.S. Food and Drug Administration (FDA) approved Hologic Inc.’s radiofrequency identification (RFID) breast lesion localization device for long-term placement.

Figure 2. Global Breast Lesion Localization Methods Market Share (%), by Device Type,  (2019-2027)

Breast Lesion Localization Methods  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing adoption of expansion strategies by major players operating in the market is expected to fuel growth of the breast lesion localization methods market

Increasing incidence and prevalence of breast cancer has led to rising demand for efficient products. Therefore, manufacturers are focusing on strengthening their market position through strategic mergers, acquisitions, and collaborations. For instance, in July 2018, Hologic Inc. and SOMATEX Medical Technologies GmbH entered into a distribution agreement. According to the agreement, Hologic Inc. will have distribution rights for SOMATEX Tumark biopsy site markers, in the U.S.

Moreover, increasing product launches is also expected to propel growth of the global breast lesion localization methods market during the forecast period. Manufacturers are expanding their product portfolio by introducing new and advanced products. For instance, in August 2018, SOMATEX Medical Technologies GmbH launched Tumark Eye, an innovative clip marking system for breast cancer with high ultrasound visibility.

Key Players

Major players operating in the global breast lesion localization methods market include Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., and Tsunami S.r.l.

Breast lesion localization methods are used to detect the abnormalities in terms of a lump or tumor in the breasts. There are various types of breast lesion localization methods used globally to detect a lump or tumor in the breasts. However, rapid increase in number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for growth of the breast lesion localization methods market.

Market Dynamics

Increasing incidence of breast cancer, increasing adoption of expansion strategies by manufacturers of lesion localization product, product launches, and increasing healthcare expenditure are major factors driving the global breast lesion localization methods market growth. For instance, on October 2018, Endomagnetics Ltd. received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for Magtrace. Megatrace is the first non-radioactive, dual-tracer used for lesion localization and sentinel node biopsy. The device will be distributed by Leica Biosystems in North America.

Furthermore, adoption of inorganic strategies such as mergers and acquisitions, and new product development by key players for expanding their product portfolio is expected to drive the market growth. For instance, in December 2017, Becton, Dickinson and Company completed acquisition of C. R. Bard, Inc. Through the acquisition, Becton, Dickinson and Company expanded its product portfolio and geographical footprint.

Key features of the study:

  • This report provides in-depth analysis of the global breast lesion localization methods market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global breast lesion localization methods market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., and Tsunami S.r.l.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global breast lesion localization methods market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global breast lesion localization methods market

Detailed Segmentation:

  • Global Breast Lesion Localization Methods Market, By Technique:
    • Wire Guided Localization
    • Radio Guided Occult Lesion Localization
    • Radioactive Seed Localization
    • Magnetic Tracers
    • Ultrasound Guided Surgery
  • Global Breast Lesion Localization Methods Market, By End User:
    • Hospitals
    • Specialized Clinics
    • Research Institutes
    • Ambulatory Surgical Centers
  • Global Breast Lesion Localization Methods Market, By Region:
    • North America
      • By Technique:
        • Wire Guided Localization
        • Radio Guided Occult Lesion Localization
        • Radioactive Seed Localization
        • Magnetic Tracers
        • Ultrasound Guided Surgery
      • By End User:
        • Hospitals
        • Specialized Clinics
        • Research Institutes
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Technique:
        • Wire Guided Localization
        • Radio Guided Occult Lesion Localization
        • Radioactive Seed Localization
        • Magnetic Tracers
        • Ultrasound Guided Surgery
      • By End User:
        • Hospitals
        • Specialized Clinics
        • Research Institutes
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technique:
        • Wire Guided Localization
        • Radio Guided Occult Lesion Localization
        • Radioactive Seed Localization
        • Magnetic Tracers
        • Ultrasound Guided Surgery
      • By End User:
        • Hospitals
        • Specialized Clinics
        • Research Institutes
        • Ambulatory Surgical Centers
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technique:
        • Wire Guided Localization
        • Radio Guided Occult Lesion Localization
        • Radioactive Seed Localization
        • Magnetic Tracers
        • Ultrasound Guided Surgery
      • By End User:
        • Hospitals
        • Specialized Clinics
        • Research Institutes
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technique:
        • Wire Guided Localization
        • Radio Guided Occult Lesion Localization
        • Radioactive Seed Localization
        • Magnetic Tracers
        • Ultrasound Guided Surgery
      • By End User:
        • Hospitals
        • Specialized Clinics
        • Research Institutes
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technique:
        • Wire Guided Localization
        • Radio Guided Occult Lesion Localization
        • Radioactive Seed Localization
        • Magnetic Tracers
        • Ultrasound Guided Surgery
      • By End User:
        • Hospitals
        • Specialized Clinics
        • Research Institutes
        • Ambulatory Surgical Centers
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Cook Medical Inc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Argon Medical Devices, Inc.
    • R. Bard, Inc.
    • SOMATEX Medical Technologies GmbH
    • Sterylab Medical
    • Biopsybell Srl
    • Hologic Inc.
    • Tsunami S.r.l

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technique
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Industry Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
    • PEST Analysis
  4. Global Breast Lesion Localization Methods Market, By Technique, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Wire Guided Localization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Radio Guided Occult Lesion Localization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Radioactive Seed Localization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Magnetic Tracers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ultrasound Guided Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Breast Lesion Localization Methods Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Specialized Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Breast Lesion Localization Methods Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Region, 2017–2026
    • North America
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Technique, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Company Profiles
      • Cook Medical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Argon Medical Devices, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • C. R. Bard, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SOMATEX Medical Technologies GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Sterylab Medical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Biopsybell Srl
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hologic Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Tsunami S.r.l
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies  
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on “Breast Lesion Localization Methods Market - Global forecast to 2027”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.